Apogee Therapeutics Inc (APGE)

10:18 AM

Apogee Therapeutics (NASDAQ:APGE) Given New $70.00 Price Target at Royal Bank Of Canada - MarketBeat

10:18 AM

06:49 AM

How to track smart money flows in Apogee Therapeutics Inc.Trade Volume Summary & Risk Controlled Stock Pick Alerts - newser.com

06:49 AM

05:07 AM

Is Apogee Therapeutics Inc. stock positioned for digital transformationWeekly Trade Review & Daily Chart Pattern Signal Reports - newser.com

05:07 AM

Nov 03, 2025

Apogee Therapeutics stock price target raised by RBC Capital to $70 - Investing.com South Africa

Nov 03, 2025

Nov 03, 2025

RBC Capital Maintains Apogee Therapeutics (APGE) Outperform Recommendation - Nasdaq

Nov 03, 2025

Nov 03, 2025

Craig-Hallum Initiates Coverage of Apogee Therapeutics (APGE) with Buy Recommendation - Nasdaq

Nov 03, 2025

Nov 03, 2025

Craig-Hallum Initiates Coverage on APGE with a 'Buy' Rating and $109 Price Target | APGE Stock News - GuruFocus

Nov 03, 2025

Nov 03, 2025

Apogee Therapeutics stock initiated with Buy rating at Craig-Hallum By Investing.com - Investing.com Australia

Nov 03, 2025

Nov 03, 2025

Apogee Therapeutics stock initiated with Buy rating at Craig-Hallum - Investing.com

Nov 03, 2025

Nov 03, 2025

Can volume confirm reversal in Apogee Therapeutics Inc.2025 Price Action Summary & Verified Momentum Stock Ideas - newser.com

Nov 03, 2025

Nov 03, 2025

How to integrate Apogee Therapeutics Inc. into portfolio analysis tools2025 Market Overview & Safe Entry Momentum Stock Tips - newser.com

Nov 03, 2025

Nov 03, 2025

Apogee Therapeutics to Participate in Upcoming Conferences - The Manila Times

Nov 03, 2025

Nov 03, 2025

Apogee Therapeutics (NASDAQ: APGE) to join five fireside chats; webcast available - Stock Titan

Nov 03, 2025

Nov 03, 2025

How to use Fibonacci retracement on Apogee Therapeutics Inc.2025 Valuation Update & High Conviction Buy Zone Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Is Apogee Therapeutics Inc. stock a dividend growth opportunityJuly 2025 Price Swings & Reliable Breakout Forecasts - newser.com

Nov 03, 2025

Nov 03, 2025

Will breakout in Apogee Therapeutics Inc. lead to full recoveryProfit Target & Trade Opportunity Analysis - newser.com

Nov 03, 2025

Nov 03, 2025

Detecting support and resistance levels for Apogee Therapeutics Inc.Jobs Report & Verified Momentum Stock Ideas - newser.com

Nov 03, 2025

Nov 02, 2025

Real time scanner hits for Apogee Therapeutics Inc. explainedJuly 2025 WrapUp & Reliable Entry Point Trade Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

How to read the order book for Apogee Therapeutics Inc.Rate Cut & Fast Exit and Entry Trade Guides - newser.com

Nov 02, 2025

Nov 02, 2025

Moody Aldrich Partners LLC Takes $939,000 Position in Apogee Therapeutics Inc. $APGE - MarketBeat

Nov 02, 2025

Nov 02, 2025

Jennison Associates LLC Sells 23,391 Shares of Apogee Therapeutics Inc. $APGE - MarketBeat

Nov 02, 2025

Oct 31, 2025

Why Apogee Therapeutics (APGE) Is Up 6.1% After $300 Million Raise to Advance APG777 - Yahoo Finance

Oct 31, 2025

Oct 31, 2025

Using data filters to optimize entry into Apogee Therapeutics Inc.July 2025 EndofMonth & Free Low Drawdown Momentum Trade Ideas - newser.com

Oct 31, 2025

Oct 30, 2025

Apogee Therapeutics: Plan To Take Standard-Of-Care Status From Dupixent Is Risky (APGE) - Seeking Alpha

Oct 30, 2025

Oct 30, 2025

Wall Street Analysts Believe Apogee Therapeutics Inc. (APGE) Could Rally 69.3%: Here's is How to Trade - sharewise.com

Oct 30, 2025

Oct 30, 2025

Mizuho Securities Keeps Their Buy Rating on Apogee Therapeutics (APGE) - The Globe and Mail

Oct 30, 2025

Oct 30, 2025

Will Apogee Therapeutics Inc. stock split attract more investorsPortfolio Value Report & Growth Focused Entry Reports - newser.com

Oct 30, 2025

Oct 27, 2025

Apogee Therapeutics’ APG777 Study: A Potential Breakthrough in Atopic Dermatitis Treatment - TipRanks

Oct 27, 2025